Advertisement
Surgical Outcomes Research| Volume 128, ISSUE 5, P847-861, November 2000

Impact of breast cancer treatment guidelines on surgeon practice patterns: Results of a hospital-based intervention

      Abstract

      Background. Despite evidence regarding the effectiveness of post-surgical treatments for early-stage breast cancer, older women are less likely to receive appropriate therapy. We evaluated the impact of surgeon-specific “performance reports” on adherence to treatment guidelines among older women with breast cancer. Methods. We obtained diagnostic and treatment data from hospital tumor registries supplemented with self-reported adjuvant therapy information on 1099 patients with stage I or II breast cancer diagnosed between November 1, 1992, and January 31, 1997, at 6 Rhode Island hospitals.We compared rates of appropriate treatment receipt before and after distribution of performance reports. Hierarchical analysis was used to account for the nesting of patients within surgeons. Separate analyses of mastectomy and breast-conserving surgery were performed. Results. Age was negatively associated with post-surgical treatment, with patients who had breast-conserving surgery and who were older than 80 years significantly less likely to undergo radiation therapy (adjusted odds ratio = 0.08 [0.04, 0.14]) or appropriate adjuvant therapies (adjusted odds ratio = 0.14 [0.08, 0.22]) or both relative to 70- to 79-year-old patients. This effect did not improve post-intervention. While there was much variability in compliance with guidelines, surgeons' characteristics did not explain this variation. Conclusions. In Rhode Island, advanced age continues to be associated with less than adequate breast cancer therapy. Providing surgeons with “feedback” on the appropriateness of adjuvant treatment for older patients was insufficient to alter established practices. Using guideline compliance data as standard “quality indicators” of physician practice may be required. (Surgery 2000;128:847-61.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Herbert-Croteau N
        • Brisson J
        • Latreille J
        • Blanchette C
        • Deschenes L.
        Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women.
        Cancer. 1999; 85: 1104-1113
        • Bergman L
        • Dekker G
        • van Leeuwen FE
        • van Kerkhoff EH
        • Peterse HL
        • van Dongen JA
        The effect of age on treatment choice and survival in elderly breast cancer patients.
        Cancer. 1991; 67: 2227-2234
        • Silliman RA
        • Guadagnoli E
        • Weitberg AB
        • Mor V.
        Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients.
        J Gerontology. 1989; 44: M46-M50
        • Mor V
        • Masterson-Allen S
        • Goldberg RJ
        • Cummings FJ
        • Glicksman AS
        • Fretwell MD
        Relationship between age at diagnosis and treatments received by cancer patients.
        J Am Geriatr Soc. 1985; 33: 585-589
        • Chung MC
        • Chang HR
        • Bland KI
        • Wanebo HJ
        Younger women with breast cancer have poorer prognosis than older women.
        Cancer. 1996; 77: 97-103
      1. Lash TL, Silliman RA, Guadagnoli E, Mor V. The effect of less than definitive care on breast cancer recurrence and mortality. Cancer (In press).

        • Petrisek A
        • Laliberte L
        • Allen S
        • Mor V.
        The treatment decision-making process: age differences in a sample of women recently diagnosed with nonrecurrent, early-stage breast cancer.
        Gerontologist. 1997; 37: 598-608
        • Ballard-Barbash R
        • Potosky AL
        • Harlan LC
        • Nayfield SG
        • Kessler LG
        Factors associated with surgical and radiation therapy for early stage breast cancer in older women.
        J Natl Cancer Inst. 1996; 88: 716-726
        • Silliman RA
        • Troyan SL
        • Guadagnoli E
        • Kaplan SH
        • Greendield S.
        The impact of age, marital status, and surgeon-patient interactions on the care of older women with breast carcinoma.
        Cancer. 1997; 80: 1326-1334
        • Hislop TG
        • Olivotto IA
        • Coldman AJ
        • Trevisan CH
        • Kula J
        • McGregor GI
        • et al.
        Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia.
        Can J Public Health. 1996; 87: 390-394
        • Kosecoff J
        • Kanouse DE
        • Rogers WH
        • McCloskey L
        • Winslow CM
        • Brook RH
        Effects of the National Institutes of Health Consensus Development Program on Surgeon Practice.
        JAMA. 1987; 258: 2708-2713
        • Kosecoff J
        • Kanouse DE
        • Brook RH
        Changing practice patterns in the management of primary breast cancer: Consensus Development Program.
        Health Serv Res. 1990; 25: 809-823
        • Marshall PS
        • Cooper S.
        Influencing surgeon prescribing through academic detailing with benchmarks.
        Am J Health Syst Pharm. 1998; 55: 2234-2236
        • Soumerai SB
        • Avorn J.
        Principles of educational outreach (‘academic detailing’) to improve clinical decision making.
        JAMA. 1990; 263: 549-556
        • Grilli R
        • Lomas J.
        Evaluating the message: the relationship between compliance rate and the subject of a practice guideline.
        Med Care. 1994; 32: 202-213
        • Grimshaw JM
        • Russell IT
        Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.
        Lancet. 1993; 342: 1317-1322
        • Lomas J
        • Anderson FM
        • Domnick-Pierre K
        • Vayda E
        • Enkin MW
        • Hannah WJ
        Do practice guidelines guide practice? The effect of a consensus statement on the practice of surgeons.
        N Engl J Med. 1989; 321: 1306-1311
        • Soumerai SB
        • McLaughlin TJ
        • Gurwitz J
        • Guadagnoli E
        • Hauptman PJ
        • Borbas C
        • et al.
        Effect of local medical opinion leaders on quality of care for acute myocardial infarction.
        JAMA. 1998; 279: 1358-1363
        • Peterson KA
        • Vinicor F.
        Strategies to improve diabetes care delivery.
        J Fam Pract. 1998; 47: S55-S62
        • Brennan TA
        The role of regulation in quality improvement.
        Milbank Q. 1998; 76 (512. Review): 709-731
        • Shortell SM
        • Bennett CL
        • Byck GR
        Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress.
        Milbank Q. 1998; 76 (510. Review): 593-624
        • National Institutes of Health
        Treatment of early stage breast cancer.
        NIH Consens Statement. 1990; 8: 1-16
        • National Institutes of Health
        Adjuvant chemotherapy for breast cancer.
        NIH Consens Statement. 1985; 5: 1-19
        • Goldhirsch AG
        • Wood W
        • Senn HJ
        • Glick JH
        • Gelber RD
        Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.
        J Natl Cancer Inst. 1995; 87: 1441-1445
        • Hortobagyi GN
        • Buzdar AU
        Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy.
        CA Cancer J Clin. 1995; 45: 199-226
        • Early Breast Cancer Trialists' Collaborative Group
        Systemic treatment of early stage breast cancer by hormonal, cytoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women.
        Lancet. 1992; 339 (Review): 1-15
        • Fisher B
        • Wickerham DL
        • Redmond C.
        Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer.
        Semin Oncol. 1992; 19: 263-277
        • Silliman RA
        • Lash TL
        Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients.
        Med Care. 1999; 37: 339-349
        • Goldstein H.
        Multilevel statistical models.
        2nd ed. Edward Arnold, London (UK)1995
        • Goldstein H
        • Robash J
        • Plewis I
        • Draper D
        • Browne W
        • Yang M
        • et al.
        A users's guide to MLwiN.
        Multilevel Models Project, Institute of Education, University of London, London (UK)1998
        • Goldstein H
        • Rasbash J.
        Improved approximations for multilevel models with binary responses.
        J Royal Statistical Soc. 1996; 159: 505-514
        • August DA
        • Rea T
        • Sondak VK
        Age-related differences in breast cancer treatment.
        Ann Surg Oncol. 1994; 1: 45-52
        • Guadagnoli E
        • Shapiro C
        • Gurwitz JH
        • Silliman RA
        • Weeks JC
        • Borbas C
        • et al.
        Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer.
        J Clin Oncol. 1997; 15: 2338-2344
        • Guadagnoli E
        • Shapiro C
        • Weeks JC
        • Gurwitz JH
        • Borbas C
        • Soumerai SB
        The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines.
        Cancer. 1998; 83: 302-309
        • Van Zyl
        • Muller A
        Tumour excision plus continuous tamoxifen compared with modified radical mastectomy in patients over 70 years of age with operable breast cancer.
        J Surg Oncol. 1995; 59: 151-154
        • Lee KS
        • Plowman PN
        • Gilmore OJA
        • Gray R.
        Tamoxifen in breast conservation therapy.
        Int J Clin Pharmacol Ther. 1995; 33: 281-284
        • Cooke AL
        • Perera F
        • Fisher B
        • Opeitum A
        • Yu N.
        Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes.
        Int J Radiat Oncol Biol Phys. 1995; 31: 777-781
        • Dalsen A
        • Vries J.
        Treatment of breast cancer in elderly patients.
        J Surg Oncol. 1995; 60: 80-82
        • Mustacchi G
        • Milani S
        • Pluchinotta A
        • De Matteis A
        • Rubagotti A
        • Perrota A.
        Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer.
        Anticancer Res. 1994; 14: 2197-2200
        • Robinson DC
        • Bloss JD
        • Schiano MA
        A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
        Gynecol Oncol. 1995; 59: 186-190
        • Fisher B
        • Costantino JP
        • Redmond CK
        • Fisher ER
        • Wickerham DL
        • Cronin WM
        Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
        J Natl Cancer Inst. 1994; 86: 527-537
        • Farley DE
        • Ozminkowski RJ
        Volume-outcome relationships and in-hospital mortality-the effect of changes in volume over time.
        Med Care. 1992; 30: 77-94
        • Hannan EL
        • Kilburn H
        • Bernard H
        • O'Donnell JF
        • Lukacik G
        • Shields EP
        Coronary-artery bypass-surgery-the relationship between in-hospital mortality-rate and surgical volume after controlling for clinical risk-factors.
        Med Care. 1991; 29: 1094-1107
        • Goldhirsch AG
        • Glick JH
        • Gelber RD
        • Senn HJ
        Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.
        J Natl Cancer Inst. 1998; 90: 1601-1608
        • Hortobagyi GN
        Treatment of breast cancer.
        N Engl J Med. 1998; 339: 974-984
        • Anderson RN
        United States Abridged Life Tables, 1996.
        Natl Vital Stat Rep. 1998; 47: 99-1120
        • Goodwin JS
        • Samet JM
        • Hunt WC
        Determinants of survival in older cancer patients.
        J Natl Cancer Inst. 1996; 88: 1031-1038
        • Fisher B
        • Dignam J
        • Bryant J
        • DeCillis A
        • Wickerham DL
        • Wolmark N
        • et al.
        Five versus more than five years of tamoxifen therapy for breast cancer patients with legative lymph nodes and estrogen receptor-positive tumors.
        J Natl Cancer Inst. 1996; 88: 1529-1542
        • Fisher B
        • Costantino J
        • Redmond C
        • Poisson R
        • Bowman D
        • Couture J
        • et al.
        A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumors.
        N Engl J Med. 1989; 320: 479-484
        • Waterhouse DM
        • Calzone KA
        • Mele C
        • Brenner DE
        Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.
        J Clin Oncol. 1993; 11: 1189-1197
        • Patnaik A
        • Doyle C
        • Oza AM
        Palliative therapy in advanced ovarian cancer: balancing patient expectations, quality of life and cost.
        Anticancer Drugs. 1998; 9: 869-878
        • Casali P
        • Licitra L
        • Costantini M
        • Santoro A
        • Viterbori P
        • Bajetta E
        • et al.
        Quality of life assessment and clinical decision-making.
        Ann Oncol. 1997; 8: 1207-1211
        • Balkrishnan R.
        Predictors of medication adherence in the elderly.
        Clin Ther. 1998; 20: 764-771
        • Coons SJ
        • Sheahan SL
        • Martin SS
        • Hendricks J
        • Robbins CA
        • Johnson JA
        Predictors of medication noncompliance in a sample of older adults.
        Clin Ther. 1994; 16: 110-117
        • Goodwin JS
        • Hunt WC
        • Samet JM
        Determinants of cancer therapy in elderly patients.
        Cancer. 1993; 72: 594-601
        • Levinson W
        • Chaumeton N.
        Communication between surgeons and patients in routine office visits.
        Surgery. 1999; 125: 127-134
        • Pignon T
        • Scalliet P.
        Radiotherapy in the elderly.
        Eur J Surg Oncol. 1998; 24: 407-411
        • Osborne CK
        Tamoxifen in the treatment of breast cancer.
        N Engl J Med. 1998; 339: 1609-1618
        • Lickley HL
        Primary breast cancer in the elderly.
        Can J Surg. 1997; 40: 341-351
        • Newschaffer CJ
        • Penberthy L
        • Desch CE
        • Retchin SM
        • Whittemore M.
        The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer.
        Arch Intern Med. 1996; 156: 85-90